Monthly Archives: February 2018

IEG Holdings Corporation (IEGH) Joins SeeThruEquity’s Blockchain Research and Advisory Platform

NEW YORK, NY / ACCESSWIRE / February 27, 2018 / SeeThruEquity, the leading independent equity research firm for publicly traded emerging growth companies, announced today that IEGH Holdings Corporation (OTCQB: IEGH) has joined its Blockchain Research and Advisory Platform.

“Since we formally launched our Blockchain and Cryptocurrency Research and Advisory practice last month, we have seen tremendous interest from companies in the space to become part of this exciting platform. We are pleased to have IEG Holdings Corporation join the platform. We look forward to supporting the company in its blockchain and cryptocurrency initiatives,” commented Ajay Tandon, CEO of SeeThruEquity.

SeeThruEquity has been an early mover in the space and as a result has developed a significant knowledge base and network of contacts including investors, service providers, and technologists in the blockchain and cryptocurrency markets which it may utilize in providing research and advisory services for companies that are in these markets or seek to enter them.

SeeThruEquity is also at the forefront of creating original and high-quality media and research content for audiences interested in blockchain and cryptocurrencies. This content will include robust blockchain and cryptocurrency industry reports on a quarterly basis as well as articles targeting specific topics in the space on a regular basis. In addition to creating these original content pieces and utilizing its already wide distribution network, SeeThruEquity will also be exploring additional avenues of exposure to expand its target audiences. This is in line with the company’s mission of bringing about visibility and awareness to this fast-growing, new market.

“With our recent announcements concerning moving IEGH into the development stage for our IEG Holdings cryptocurrency and combining the exciting new blockchain technology with a leading sophisticated online consumer finance system, individual US state lending licenses and exposure to the Philippines $28 billion OFW remittance sector is a very exciting proposition for our company. We are very excited to have joined SeeThruEquity’s blockchain platform which we believe will provide the market with much needed information and awareness of this new space. We look forward to working with SeeThruEquity as we believe them to be a key player in the blockchain/cryptocurrencies research and advisory space,” stated Paul Mathieson, CEO of IEG Holdings Corporation

Blockchain and cryptocurrency, including BitCoin, have received a lot of attention in the media in 2017 and SeeThruEquity believes that this will continue in 2018 and beyond. The company believes this is only the very early phase of the growth in these markets and believes it is uniquely positioned to serve the needs of companies that seek to leverage these technologies.

SeeThruEquity has long been an innovator in the equity research space with the most unique business model in the equity research industry which is focused on getting research coverage to emerging growth companies which historically have faced a challenge in attracting the attention of the old world, institutional providers of equity research, and as a result, has grown its coverage universe to over 230 companies since its founding in 2011.

About IEG Holdings Corporation

IEG Holdings Corporation is an SEC reporting fintech company that provides online $5,000 and $10,000 unsecured consumer loans under the brand name, “Mr. Amazing Loans”, via its website and online application portal at www.mramazingloans.com. IEG Holdings is a direct lender with state licenses and/or certificates of authority in 20 US states, with all loans originated, processed and serviced out of our centralized Las Vegas head office.

Investment Evolution Crypto LLC (“IE Crypto”) is a wholly owned subsidiary of IEG Holdings that plans to offer loans and accept loan repayments in its own IEG Holdings cryptocurrency. IE Crypto also plans to offer Philippines remittance and loan services to Filipino OFWs based in the US and Australia utilizing IEG Holdings’ cryptocurrency. IE Crypto is in the development planning stages to explore these crypto/blockchain business opportunities. For more information about IEG Holdings, visit www.investmentevolution.com.

About SeeThruEquity

Since its founding in 2011, SeeThruEquity has been committed to its core mission: providing impactful, high quality research on underfollowed smallcap and microcap equities. SeeThruEquity has pioneered an innovative business model for equity research that is not paid for and is unbiased. SeeThruEquity is the host of acclaimed investor conferences that are the ultimate event for publicly traded companies with market capitalizations less than $1 billion.

SeeThruEquity is approved to contribute its research reports and estimates to Thomson One Analytics (First Call), the leading estimates platform on Wall Street, as well as Capital IQ and FactSet. SeeThruEquity maintains one of the industry’s most extensive databases of opt-in institutional and high net worth investors. The firm is headquartered in Midtown Manhattan in New York City.

For more information about the new blockchain practice, please contact SeeThruEquity at (646) 495-0939 or info@seethruequity.com.

The corporate website can be found at www.seethruequity.com.

Contact:

SeeThruEquity
info@seethruequity.com

SOURCE: SeeThruEquity

ReleaseID: 490881

Hangar Network’s New Mobile Website Is Changing The Face Of Aviation Real Estate

Hangar Network LLC releases a new mobile-friendly website that will change things in aviation real estate by adding a level of convenience not seen with other sites in the industry.

Centennial, United States – February 27, 2018 /PressCable/ —

Earlier today, Hangar Network, LLC announced the launch of its new mobile-friendly website, which went live on February 15, 2018. For investors, brokers, and pilots seeking airport and aviation-related real estate such as hangars, airpark hangar-homes, offices, shop/warehouse space, and airport development land, the new mobile-friendly interface will make people notice because of its convenience.

Most people using the hangarnetwork.com website already know its search features are more robust than any other site in the space. With the new, adaptive mobile interface, those seeking a hangar or other airport properties can search by city, state, or airport code even while they’re on the go, and also request contacts from listing parties directly from their mobile device. Hangar Network’s Director of Operations, Mike Straka, points out, “The mobile website mirrors all the features of the desktop version, and because it is adaptive – that is, it detects the exact device being used and delivers the appropriate display – the new interface makes the website so much more accessible across a much broader range of devices, including iPhones, iPads, Android devices, and tablets.”

Mr. Straka continues, “Competitors are doing the same old thing, but Hangar Network is the leading resource for aviation properties nationwide, and of the other sites in this industry, to our knowledge none have the capability that enables searching for hangars for sale or lease from a mobile device. We’ve provided this because a mobile interface is standard for all websites now, particularly those delivering rich payloads of real estate information and in our case, airport and aviation properties such as development land, hangars, offices, shops, warehouses, and other spaces available for sale or lease. Ultimately this will prove to be a huge benefit because searching for aviation properties just got much easier and more convenient to view listing information and photos, and request contacts from the listing party right on your mobile device.”

Hangar Network was established in February 2013, and has always been the leading innovator in the space, due to the firm belief that innovation drives progress, and the greater convenience provided by the mobile release means more satisfied users of the website.

“We believe no other website in this space has as full-featured and robust a mobile-friendly display,” Straka said. “This alone will make Hangar Network even more popular with customers. In fact, we’ve already seen a significant jump in the number of contacts requested of listing agents from mobile devices. That means people are finding the mobile display very easy to use as well as convenient, and are taking advantage of that convenience. In the world of aviation real estate, such convenience often means the difference between finding a hangar for sale or lease, or not,” said Straka.

Once again, the mobile website went live on February 15, 2018. To find out more, the place to visit is https://www.hangarnetwork.com

Contact Info:
Name: Mike Straka, PhD
Email: mstraka@hangarnetwork.com
Organization: Hangar Network, LLC
Address: 2221 East Arapahoe Road Suite 2192, Centennial, Colorado 80122, United States
Phone: +1-855-942-6427

For more information, please visit https://www.hangarnetwork.com

Source: PressCable

Release ID: 305554

Misee Harris Jonesboro Arkansas Pediatric Dentist Expands Service Area

Dr. Misee Harris, a Celebrity Pediatric Dentist of Jonesboro Arkansas, has recently expanded her service area. She makes the case that if you are within 50mi of Jonesboro, then you should not settle for anything less than the best care possible.

Jonesboro, United States – February 27, 2018 /PressCable/ —

When it comes to finding a local pediatric dentist, Jonesboro has many, yet their service area is fairly limited. This is inconvenient for those who are not very far and are seeking high-quality services.

You can see the Misee Harris Pediatric Dentistry Jonesboro service page, here: https://miseeharris.com/1-pediatric-dentist-jonesboro-ar/

This has all changed recently after local pediatric dentist, Dr. Misee Harris, began to reach out to patients who are up to 50 miles from her office location. Finding a good pediatric dentist is a big moment for those who want to receive the best available coverage, yet were denied in the past due to location constraints.

All parents with small children know how difficult it is to find great dental services. A lot of people simply go to whatever is close by, but it’s really not that big a deal to drive a little further, a couple times a year, to see a really good Pediatric Dentist. Misee’s goal is to provide the best pediatric dental care for as many kids as possible.

Every dentist is not equally qualified and if someone is not satisfied with the current option that is in use, it only makes sense to explore what’s out there. Instead of settling for the dental specialist right around the corner, it is possible to explore a wider area and take advantage of top-notch dentistry for kids.

There is no need to question whether or not a particular city is covered. As long as it is within 50 miles of Jonesboro, Arkansas, it is in the coverage area that has been previously specified. For those who have been making do with dentists that are not up to par, this does not have to be the case any longer.

It is now possible to pick up the phone, call Misee Harris, the premiere local pediatric dentist in the Jonesboro area, and be given an appointment to see a trusty provider. Anyone who is seeking a pediatric dentist should certainly keep this in mind.

Some of the NEW cities Dr. Misee Harris is now Serving:

Jonesboro AR, State University AR, Brookland AR, Bono AR, Bay AR, Walcott AR, Lake City AR, Sedgwick AR, Egypt AR, Cash AR, Black Oak AR, Trumann AR, Paragould AR, Weiner AR, Beech Grove AR, Monette AR, Harrisburg AR, Light AR, Minturn AR, Caraway AR, Walnut Ridge AR, Hoxie AR, Rivervale AR, Alicia AR, O Kean AR, Waldenburg AR, Lepanto AR, Cardwell MO, Grubbs AR, Marked Tree AR, Lafe AR, Portia AR, Marmaduke AR, Fisher AR, Amagon AR, and many more.

To see a full list of the cities nearby Dr. Misee Harris, check out this link: https://miseeharris.com/locations/

Contact Info:
Name: Dr. Misee Harris
Organization: Dr. Misee Harris
Address: 809 Windover Road, Jonesboro, AR 72401, United States
Phone: +1-870-931-3337

For more information, please visit https://miseeharris.com/

Source: PressCable

Release ID: 305474

Balchem Corporation to Host Earnings Call

NEW YORK, NY / ACCESSWIRE / February 27, 2018 / Balchem Corporation (NASDAQ: BCPC) will be discussing their earnings results in their Q4 Earnings Call to be held on February 27, 2018 at 11:00 AM Eastern Time.

To listen to the event live or access a replay of the call – visit https://www.investornetwork.com/company/23529

To receive updates for this company you can register by emailing info@investornetwork.com or by clicking get investment info from the company’s profile.

About Investor Network

Investor Network (IN) is a financial content community, serving millions of unique investors market information, earnings, commentary and news on the what’s trending. Dedicated to both the professional and the average traders, IN offers timely, trusted and relevant financial information for virtually every investor. IN is an Issuer Direct brand, to learn more or for the latest financial news and market information, visit www.investornetwork.com. Follow us on Twitter @investornetwork.

SOURCE: Investor Network

ReleaseID: 490549

Key Energy Services, Inc. to Host Earnings Call

NEW YORK, NY / ACCESSWIRE / February 27, 2018 / Key Energy Services, Inc. (NYSE: KEG) will be discussing their earnings results in their Q4 Earnings Call to be held on February 27, 2018 at 11:00 AM Eastern Time.

To listen to the event live or access a replay of the call – visit https://www.investornetwork.com/company/990

To receive updates for this company you can register by emailing info@investornetwork.com or by clicking get investment info from the company’s profile.

About Investor Network

SOURCE: Investor Network

ReleaseID: 490550

CorMedix Inc. Provides Update on Its Financing Plans in Connection with Its Ongoing LOCK-IT 100 Clinical Study

BERKELEY HEIGHTS, NJ / ACCESSWIRE / February 27, 2018 / CorMedix Inc. (NYSE American: CRMD), a biopharmaceutical company focused on developing and commercializing therapeutic products for the prevention and treatment of infectious and inflammatory disease, today provided guidance regarding the actions it may undertake to meet any additional capital needs prior to the anticipated interim efficacy analysis of its LOCK-IT 100 clinical study.

Khoso Baluch, Chief Executive Officer of CorMedix, stated, “We are working as quickly and as diligently as possible to complete the quality assurance procedures necessary for the interim efficacy analysis and subsequent review by the Data Safety Monitoring Board (DSMB). We understand the financial impact of each week we spend in this effort and, at the same time, we recognize the need to ensure the accuracy and completeness of the data required for conducting the interim efficacy analysis. Given our poor current market valuation, we intend to minimize dilution to our shareholders by adhering to our financial strategy of raising as small an amount of capital as necessary to get us through the DSMB’s review.”

Based on the Company’s current cash resources, the estimated cost of continuing the LOCK-IT 100 clinical study until the interim efficacy analysis is completed, and by reducing or delaying other activities until after the results of the interim efficacy analysis are known, the Company believes it will be able to fund operations into June 2018 and anticipates that any remaining short-term capital needs may be met through small opportunistic financings similar to those it completed during the fourth quarter of 2017.

The Company expects to report its fourth quarter and full year 2017 financial results on March 19, 2018.

About CorMedix

CorMedix Inc. is a biopharmaceutical company focused on developing and commercializing therapeutic products for the prevention and treatment of infectious and inflammatory diseases. The Company is focused on developing its lead product Neutrolin®, a novel, non-antibiotic antimicrobial solution designed to prevent costly and dangerous bloodstream infections associated with the use of central venous catheters, currently in a Phase 3 clinical trial enrolling patients undergoing chronic hemodialysis. Such infections cost the U.S. healthcare system approximately $6 billion annually and contribute significantly to increased morbidity and mortality. Neutrolin has FDA Fast Track status and is designated as a Qualified Infectious Disease Product, which provides the potential for priority review of a marketing application by FDA and allows for 5 additional years of QIDP market exclusivity in the event of U.S. approval. Neutrolin is already marketed as a CE Marked product in Europe and other territories. In parallel, CorMedix is leveraging its taurolidine technology to develop a pipeline of antimicrobial medical devices, with active programs in surgical sutures and meshes, and topical hydrogels. The company is also working with top-tier researchers to develop taurolidine-based therapies for rare pediatric cancers. For more information, visit: www.cormedix.com.

Forward-Looking Statements

This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995, including with respect to possible uses of taurolidine, that are subject to risks and uncertainties. All statements, other than statements of historical facts, regarding management’s expectations, beliefs, goals, plans or CorMedix’s prospects, future financial position, financing plans, future revenues and projected costs should be considered forward-looking. Readers are cautioned that actual results may differ materially from projections or estimates due to a variety of important factors, including: the possible inability to capture sufficient CRBSI events in the ongoing Phase 3 clinical trial for Neutrolin®; the cost, timing and results of the ongoing and planned Phase 3 trials for Neutrolin® in the U.S. and the resources needed to commence and complete those trials; the risks and uncertainties associated with CorMedix’s ability to manage its limited cash resources and the impact on current, planned or future research, including the ongoing LOCK-IT 100 trial and research for additional uses for taurolidine; obtaining additional financing to support CorMedix’s research and development and clinical activities and operations; preclinical results are not indicative of success in clinical trials and might not be replicated in any subsequent studies or trials; and the ability to retain and hire necessary personnel to staff our operations appropriately. These and other risks are described in greater detail in CorMedix’s filings with the SEC, copies of which are available free of charge at the SEC’s website at www.sec.gov or upon request from CorMedix. CorMedix may not actually achieve the goals or plans described in its forward-looking statements, and investors should not place undue reliance on these statements. CorMedix assumes no obligation and does not intend to update these forward-looking statements, except as required by law.

Investor Contacts:

Dan Ferry
Managing Director
LifeSci Advisors
617-535-7746

SOURCE: CorMedix Inc.

ReleaseID: 490879

Blue Point and Italian Rose Show Good Taste with the Acquisition of La Mexicana Food Products

CLEVELAND, OH / ACCESSWIRE / February 27, 2018 / Blue Point Capital Partners and its Blue Point III portfolio company, Italian Rose Gourmet Products, announced the acquisition of La Mexicana Food Products (www.lamexicanasalsa.com), a fresh, refrigerated salsa manufacturer based in Vernon, California.

This transaction represents the first add-on acquisition for Italian Rose since Blue Point acquired the platform investment three months ago, in November 2017.

“From the time of our initial investment in Italian Rose, we saw significant opportunities to broaden the Company’s market presence. The acquisition of La Mexicana, one of the leading fresh salsa brands in the country, will enable the combined Company to present a unique value proposition to salsa buyers nationwide,” said Jonathan Pressnell, a Principal with Blue Point.

Italian Rose (www.italian-rose.com), headquartered in West Palm Beach, Florida, is a leading manufacturer and distributor of premium salsas, dips, sauces, and spreads to major retail and food service channels. The addition of La Mexicana’s West Coast operations to Italian Rose’s East Coast presence will put the combined Company in a select universe of truly national salsa producers, as well as provide increased scale, production diversity and product breadth to both companies’ customers.

“The strength of the two companies has been their brands and recipes that have endured over time. We will continue to develop and expand both companies to allow more consumers to enjoy the ‘fresh to table’ experience on a national basis,” said Angelo Fraggos, an Operating Executive with Blue Point and CEO of Italian Rose.

“For a combined 60 years, Italian Rose and La Mexicana have been manufacturing and distributing fresh, better-for-you products, and their efforts continue to redefine industry standards,” said John LeMay, a Partner with Blue Point. “Combining these two industry leaders was a natural and complementary fit. We are thrilled to add La Mexicana to the Italian Rose family.”

Blue Point Capital Partners (www.bluepointcapital.com) is a private equity firm managing over $1.5 billion in committed capital. With offices in Cleveland, Charlotte, Seattle, and Shanghai, Blue Point’s geographical footprint allows it to establish relationships with local and regional entrepreneurs and advisors while providing the resources of a larger, global organization. The Blue Point partner group has a 19-year track record of partnering with companies in the lower middle-market to facilitate growth and transformative change. It is one of only a few middle market private equity firms with a presence in both the United States and China, which provides a distinct advantage for its portfolio companies. Blue Point typically invests in businesses that generate between $20 million and $200 million in revenue.

For more information, contact:

BLUE POINT CAPITAL PARTNERS
127 Public Square, Suite 5100
Cleveland, OH 44114

John LeMay
Partner
(216) 535-4707
jlemay@bluepointcapital.com

Jonathan Pressnell
Principal
(216) 535-4713
jpressnell@bluepointcapital.com

SOURCE: Blue Point Capital Partners

ReleaseID: 490735

ANI Pharmaceuticals, Inc. to Host Earnings Call

NEW YORK, NY / ACCESSWIRE / February 27, 2018 / ANI Pharmaceuticals, Inc. (NASDAQ: ANIP) will be discussing their earnings results in their Q4 Earnings Call to be held on February 27, 2018 at 10:30 AM Eastern Time.

To listen to the event live or access a replay of the call – visit https://www.investornetwork.com/company/23410

To receive updates for this company you can register by emailing info@investornetwork.com or by clicking get investment info from the company’s profile.

About Investor Network

SOURCE: Investor Network

ReleaseID: 490543

AMERISAFE, Inc. to Host Earnings Call

NEW YORK, NY / ACCESSWIRE / February 27, 2018 / AMERISAFE, Inc. (NASDAQ: AMSF) will be discussing their earnings results in their Q4 Earnings Call to be held on February 27, 2018 at 10:30 AM Eastern Time.

To listen to the event live or access a replay of the call – visit https://www.investornetwork.com/company/23396

To receive updates for this company you can register by emailing info@investornetwork.com or by clicking get investment info from the company’s profile.

About Investor Network

SOURCE: Investor Network

ReleaseID: 490545

FreightCar America, Inc. to Host Earnings Call

NEW YORK, NY / ACCESSWIRE / February 27, 2018 / FreightCar America, Inc. (NASDAQ: RAIL) will be discussing their earnings results in their Q4 Earnings Call to be held on February 27, 2018 at 11:00 AM Eastern Time.

To listen to the event live or access a replay of the call – visit https://www.investornetwork.com/company/22604

To receive updates for this company you can register by emailing info@investornetwork.com or by clicking get investment info from the company’s profile.

About Investor Network

SOURCE: Investor Network

ReleaseID: 490547